Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhongyan Pharmaceutical Technology is a contract research and development organization (CRO/CDMO) based in Hangzhou, China, specializing in small molecule drug discovery and chemical process development. The company provides integrated services ranging from medicinal chemistry and custom synthesis to the production of advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Zhongyan Pharma focuses on accelerating the drug development process through innovative chemical synthesis and process optimization, serving a global clientele in the pharmaceutical and biotechnology sectors. Their technical expertise includes complex multi-step synthesis, asymmetric catalysis, and the development of scalable, cost-effective manufacturing routes. The firm operates modern laboratory facilities designed to meet international quality standards for pharmaceutical research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 浙江众延医药科技.